Studies on rodent models of hypertension induced by Angiotensin II [95], mineralocorticoid‐dependent hypertension [97], hypertension in response to cyclosporine A [98], or in a model of pre‐eclampsia [99] with IL‐17 attenuation by genetic intervention or by receptor blockade have all shown that a lack of IL‐17 prevents hypertension. This evidence concerns the gene IL17A and hypertensive disorder.